While A/T are largely accepted as specific to AD diagnosis, regardless of the why and how [[18], [19], [20], [21]], the same cannot be said about N. NfL is just one of several different plasma biomarkers of neurodegeneration [22,23], but given its widespread use, it has emerged as a well-accepted measure of neurodegeneration. This evidence concerns the gene NEFL and Alzheimer disease.